| |
| |
|
| Insider
Information: |
Riggs Rory B |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
3,917,677 |
|
|
Indirect Shares
|
724,607 |
|
|
| Direct
Value |
$37,890,143 |
|
|
|
Indirect Value
|
$3,572,078 |
|
|
| Total
Shares |
4,642,284 |
|
|
| Total
Value |
$41,462,220 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
30
|
|
Stock
price went up :
|
0
|
12
|
| Stock
price went down : |
3
|
18
|
| |
|
|
|
Gain/Loss Ratio : |
-3.0
|
-3.0
|
| Percentage
Gain/Loss : |
 -19.3%
|
-184.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fibrogen Inc |
FGEN |
Director |
2021-05-26 |
395,750 |
2021-05-26 |
605,713 |
Premium* |
|
|
Royalty Pharma Plc |
RPRX |
Director |
2024-02-20 |
320,099 |
2024-02-20 |
100,187 |
Premium* |
|
|
Cibus Inc |
CBUS |
|
2024-06-11 |
3,201,828 |
2024-06-11 |
18,707 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2023-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,747 |
14,509 |
0 |
- |
|
| CBUS |
Cibus Inc |
Chief Executive Officer |
• • • |
2023-09-27 |
4 |
D |
$0.00 |
$0 |
I/I |
(39,476) |
1,105,388 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2023-11-13 |
4 |
A |
$0.00 |
$0 |
D/D |
475,590 |
490,099 |
0 |
- |
|
| CBUS |
Cibus Inc |
Chief Executive Officer |
• • • |
2023-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500,000 |
1,367,193 |
0 |
- |
|
| CBUS |
Cibus Inc |
Chief Executive Officer |
• • • |
2023-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,505,967 |
2,867,193 |
0 |
- |
|
| CBUS |
Cibus Inc |
Chief Executive Officer |
• • • |
2023-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500,000 |
3,103,788 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2024-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
320,099 |
0 |
- |
|
| CBUS |
Cibus Inc |
Chief Executive Officer |
• • • |
2024-06-11 |
4 |
A |
$10.20 |
$1,000,008 |
D/D |
98,040 |
3,201,828 |
0 |
- |
|
| CBUS |
Cibus Inc |
Chief Executive Officer |
• • • |
2023-12-12 |
4 |
B |
$10.58 |
$5,470,992 |
D/D |
517,107 |
1,622,495 |
0.01 |
% |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2016-12-16 |
4 |
S |
$20.87 |
$417,310 |
D/D |
(20,000) |
460,200 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2024-01-04 |
4 |
S |
$27.55 |
$983,504 |
D/D |
(35,702) |
20,099 |
0 |
% |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2015-09-11 |
4 |
S |
$27.56 |
$675,927 |
D/D |
(24,429) |
505,771 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2015-09-14 |
4 |
S |
$27.56 |
$704,737 |
D/D |
(25,571) |
480,200 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2024-01-03 |
4 |
S |
$27.79 |
$5,532,276 |
D/D |
(199,098) |
55,801 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2020-06-18 |
4 |
B |
$28.00 |
$420,000 |
I/I |
15,000 |
15,000 |
2.1 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2024-01-02 |
4 |
S |
$28.52 |
$6,707,081 |
D/D |
(235,200) |
254,899 |
0 |
% |
|
| CBUS |
Cibus Inc |
Chief Executive Officer |
• • • |
2023-06-01 |
4 |
B |
$31.50 |
$31,500 |
D/D |
1,000 |
1,154,464 |
3.23 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2023-05-22 |
4 |
S |
$32.82 |
$57,435,000 |
D/D |
(1,750,000) |
6,762 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2023-03-30 |
4 |
S |
$36.26 |
$4,714,345 |
D/D |
(130,024) |
1,456,762 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-09-29 |
4 |
S |
$36.31 |
$2,318,494 |
I/I |
(63,777) |
2,074,540 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-09-29 |
4 |
S |
$36.50 |
$899,706 |
D/D |
(24,648) |
615,112 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-09-28 |
4 |
S |
$36.75 |
$1,470,088 |
D/D |
(40,000) |
639,760 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2023-03-29 |
4 |
S |
$36.95 |
$366,766 |
D/D |
(9,926) |
1,586,786 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-03-29 |
4 |
S |
$38.59 |
$2,315,322 |
D/D |
(60,000) |
601,712 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-03-21 |
4 |
S |
$39.05 |
$1,556,846 |
I/I |
(39,867) |
0 |
0 |
% |
|
74 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
